2015
DOI: 10.1016/j.jpedsurg.2014.10.053
|View full text |Cite
|
Sign up to set email alerts
|

Protective effects of dexpanthenol in an experimental model of necrotizing enterocolitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
16
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 31 publications
(16 citation statements)
references
References 32 publications
0
16
0
Order By: Relevance
“…All of these play a major role in cellular defense and in the repair systems against oxidative stress and inflammatory response. A large number of experiments have proved that dexpanthenol has anti‐inflammatory and antioxidant properties (Karadag et al, ; Liew, Jee, Yap, & Yong, ; Ozdemir et al, ). Based on the above evidence, the increase in pantothenic acid in the MF‐treated group contributed to alleviating lung injury.…”
Section: Discussionmentioning
confidence: 99%
“…All of these play a major role in cellular defense and in the repair systems against oxidative stress and inflammatory response. A large number of experiments have proved that dexpanthenol has anti‐inflammatory and antioxidant properties (Karadag et al, ; Liew, Jee, Yap, & Yong, ; Ozdemir et al, ). Based on the above evidence, the increase in pantothenic acid in the MF‐treated group contributed to alleviating lung injury.…”
Section: Discussionmentioning
confidence: 99%
“…Dexpanthenol (DXP) is an alcoholic analog of pantothenic acid which is oxidized to pantothenic acid inside the peripheral tissues. It reduces the ultraviolet‐induced decrease of glutathione content, attenuates lipid peroxidation, and partly protects the cells against apoptosis produced by ultraviolet irradiation 2,3 . It also induces the co‐enzyme A and ATP synthesis within the cell.…”
mentioning
confidence: 99%
“…Also as these newer modalities are expensive, the ability to define a population which may be at risk for developing severe disease, these diagnostic and treatment modalities can be used judiciously for at risk population. [27][28][29][30] Our findings are limited by the retrospective nature of our study, although we validated the data extraction from charts, variation in nursing documentation of clinical signs may have altered our findings. Use of this multi-parameter scoring tool to determine whether more aggressive treatment for at risk infants for developing NEC stage 2 and 3, even before radiological confirmation of pneumatosis intestinalis, may result in a less severe course of NEC and improve morbidity and mortality.…”
Section: Discussionmentioning
confidence: 83%